Companion Animal Specialty Drug is a kind of veterinary drugs that pet owners used to treatment and care of animals.
Due to the COVID-19 pandemic, the global Companion Animal Specialty Drugs market size is estimated to be worth US$ 12530 million in 2021 and is forecast to a readjusted size of US$ 17200 million by 2028 with a CAGR of 4.6% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Companion Animal Specialty Drugs market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Companion Animal Specialty Drugs landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
The Americas has the presence of large veterinary markets such as the US and Canada. The companion animal specialty drugs market is witnessing continuous growth in the region due to the rising awareness and the availability of companion animal healthcare. Furthermore, the increase in disposable incomes of pet owners and economic development, will also contribute to the growth of the market in this region.
This report focuses on Companion Animal Specialty Drugs volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Companion Animal Specialty Drugs market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Companion Animal Specialty Drugs Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Vaccines
Antibiotics
Parasiticides
Feed Additives
Other
Segment by Application
Veterinary Hospitals
Pet Care Clinics
Pharmacy Stores
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Bayer
Elanco
Merial
Zoetis
Aratana therapeutics
Beaphar
Henry Schein
Mars
The J.M Smucker Company